Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Conditions: Hodgkin Lymphoma Interventions: Other: observational Sponsors: Federico II University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials